-
2023-508208-40-00
10
2024-11-21
All adult patients with successful transfemoral trans-aortic valve imp
-
2024-516242-19-00
5
2024-11-05
lupus nephritis
-
2022-501019-15-00
9
2024-10-22
Acute Leukemia
-
2023-507482-26-00
5
2024-10-04
Castrate-resistant prostate cancer with oligometastases on functional
-
2023-508260-30-01
5
2024-07-30
Patients with poor prognostic OVARian cancers based on the tumor prima
-
2023-509905-62-00
5
2024-07-19
Lower limb trauma requiring immobilisation
-
2024-518259-49-00
5
2024-07-04
Mental Disorder
-
2024-518455-28-00
4
2024-07-03
Patients with severe Alcohol Use Disorder (according to DSM 5) at entr
-
2023-505112-38-00
11
2024-07-01
recently active non-infectious intermediate, posterior, and pan-uveiti
-
2024-513371-41-00
4
2024-04-25
Severe uveitis of Behçet’s disease
-
2024-513328-40-00
6
2024-03-25
Pyelonephritis
-
2022-502007-30-00
5
2023-11-07
Kidney transplant
-
2022-502426-41-00
5
2023-10-17
Thromboprophylaxis in good and intermediate prognosis advanced germ ce
-
2022-502157-33-00
7
2023-09-18
B-Cell Malignancies
-
2022-500967-11-00
5
2023-07-06
Previously Untreated Metastatic or Unresectable Melanoma
-
2024-513811-29-00
5
2023-07-03
Cardiogenic Shock
-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2024-515146-16-00
5
2023-05-15
Colorectal surgery
-
2024-511896-13-00
11
2022-12-09
EA-COPD (with mechanical ventilation, invasive or non-invasive, or hig
-
2022-500197-34-01
4
2022-11-03
Megalencephaly-CApillary malformation Polymicrogyria syndrome
-
2024-514042-36-00
5
2022-09-21
Adult patients admitted to intensive care
-
2024-513327-16-00
5
2022-09-20
Intensive care
-
2022-500295-60-00
4
2022-09-15
Acute Myeloid Leukemia
-
2024-511899-32-00
10
2022-08-31
Dermatomyositis; Baricitinib in patients with relapsing or naïve derma